The Food and Drug Administration announced on Monday it has given full approval for a new preventative injection for infants under age 2 to protect them from contracting respiratory syncytial virus, or RSV.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.